ctrl K

Price Alert

Enact Inc. (ACT)

NASDAQ: ACT · Real-Time Price · USD

38.70

0.17 (0.44%)

At close: Sep 24, 2025, 3:59 PM

38.70

0.00%

After-hours: Sep 24, 2025, 06:06 PM EDT

Enact Revenue Breakdown

Period Ending	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
Actavis Pharma Segment Revenue	24.9M	43.7M	9.7M
Actavis Pharma Segment Revenue Growth	-43.02%	+350.52%	n/a
Actavis Specialty Brands Segment Revenue	16.1M	17.9M	14.5M
Actavis Specialty Brands Segment Revenue Growth	-10.06%	+23.45%	n/a
Anda Distribution Segment Revenue	307.1M	275.8M	231M
Anda Distribution Segment Revenue Growth	+11.35%	+19.39%	n/a

Revenue by Geography

Period Ending	Dec 31, 2012
United States Revenue	4.72B
United States Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Selling, General, and Administrative Revenue	n/a	n/a	n/a	n/a	112.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling, General, and Administrative Revenue Growth	n/a	n/a	n/a	-100.00%	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research and Development Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Research and Development Revenue Growth	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a

Ask AI